BioSpace News Archive

Press Releases

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference

February 24, 2026
·
10 min read
Press Releases

New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer

February 24, 2026
·
8 min read
Press Releases

Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026

February 24, 2026
·
7 min read
Press Releases

Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052

February 24, 2026
·
5 min read
Press Releases

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook

February 24, 2026
·
25 min read
Press Releases

Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

February 24, 2026
·
11 min read
Press Releases

Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET

February 24, 2026
·
3 min read
Press Releases

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

February 24, 2026
·
13 min read
Press Releases

Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms

February 24, 2026
·
6 min read
Press Releases

AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor

February 24, 2026
·
6 min read